🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial studies the best dose and side effects of utomilumab (4-1BB agon...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2017-10-30
Trial ID
NCT03364348
Treatments Being Tested
The goal of this clinical research study is to learn if utomilumab, when gi...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2018-04-04
Trial ID
NCT03258008
Treatments Being Tested
A study of PF-05082566, a 4-1BB agonist monoclonal antibody (mAb), in patie...
Status
Completed
Location
City of Hope
Start Date
2011-06-21
Trial ID
NCT01307267
Treatments Being Tested
This phase II trial studies how well the combination of avelumab with lipos...
Status
Active Not Recruiting
Location
O'Neal Comprehensive Cancer Center
Start Date
2019-07-08
Trial ID
NCT03971409
This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacoki...
Status
Terminated
Location
UCSD Medical Center - Encinitas
Start Date
2015-11-09
Trial ID
NCT02554812
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-06-21
Trial ID
NCT03414658
Treatments Being Tested
This study is a Phase 1b, open label, multi center, multi-dose trial design...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2015-05
Trial ID
NCT02444793
Treatments Being Tested
This Master Protocol for Avelumab Continuation Sub-Studies is to provide co...
Status
Active Not Recruiting
Location
Highlands Oncology Group, PA
Start Date
2021-09-29
Trial ID
NCT05059522
Treatments Being Tested
This phase I/II trial studies the side effects of avelumab when given in di...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-08-02
Trial ID
NCT03217747
Treatments Being Tested
This is a safety, pharmacokinetic and pharmacodynamic study designed to est...
Status
Completed
Location
Research Administration Office
Start Date
2014-08
Trial ID
NCT02179918
Treatments Being Tested